Roche will also have exclusive access to Carmot’s Chemotype Evolution discovery platform in metabolism to further strengthen Roche’s R&D efforts and portfolio across cardiovascular and metabolic diseases.

Source: https://www.benzinga.com/general/biotech/23/12/36064233/roche-joins-bandwagon-to-challenge-novo-nordisk-eli-lilly-for-weight-loss-drugs

"These types of compounds have been related to the promotion of human health and also to the prevention of degenerative and metabolic diseases."

Source: https://www.ibtimes.com.au/what-makes-ripe-strawberries-red-researchers-shed-light-fruits-puzzle-1845597